Article Page

Abstract

In this paper, I shall sketch a new way to consider a Lindenbaum-Tarski algebra as a 3D logical space in which any one (of the 256 statements) occupies a well-defined position and it is identified by a numerical ID. This allows pure mechanical computation both for generating rules and inferences. It is shown that this abstract formalism can be geometrically represented with logical spaces and subspaces allowing a vectorial representation. Finally, it shows the application to quantum computing through the example of three coupled harmonic oscillators of a novel multi-chemo-structure super-agonistic CellshOX Decoy Peptide Mimetic Construct as a Human Umbilical Cord blood Stem Cell Expansion Molecule in a QSAR automating modeling lead compound design approach.

Keywords

Lindenbaum-Tarski Algebra; 3D Logical Space; Mechanical Computation; Inference; Quantum Computing; Raising Operators; Lowering Operators; Implement Quantum Computation; In silico discovery; multi-chemo-structure; super-agonistic; CellshOX; Decoy Peptide; Mimetic Construct; Human Umbilical Cord blood; Stem Cell Expansion Molecule; QSAR automating modeling; lead compound; design approach;

Article Type

Research Article – Abstract

Publication history

Received: Sep 20, 2017
Accepted: Sep 25, 2017
Published: Oct 01, 2017

Citation

Grigoriadis Ioannis, Grigoriadis George, Grigoriadis Nikolaos, George Galazios (2017) A New Way to Implement Quantum Computation In silico Lindenbaum-Tarski algebra as a 3D logical space discovery of a novel multi-chemo-structure super-agonistic CellshOX Decoy Peptide Mimetic Human Umbilical Cord blood Stem Cell Expansion Molecule Construct in a QSAR automating modeling lead compound design approach.

Authors Info

Grigoriadis Nikolaos
Department of IT Computer Aided Personalized Myoncotherapy, Cartigenea-Cardiogenea, Neurogenea-Cellgenea, Cordigenea-HyperoligandorolTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;

Grigoriadis Ioannis
Department of Computer Drug Discovery Science, BiogenetoligandorolTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;

Grigoriadis George
Department of Stem Cell Bank and ViroGeneaTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;

George Galazios
Professor of Obstetrics and Gynecology,
Democritus University of Thrace,
Komotini, Greece;

E-mail: biogeneadrug@gmail.com

File not available